Physician profile
Kyle Potts
NPI 1215390521
$13,674.38
in general payments reported to CMS, 2019-2025
5 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $77.52 · 2021: $286 · 2022: $271 · 2023: $13K · 2024: $23.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Travel and Lodging: $621 · Food and Beverage: $419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,000.00 |
| Travel and Lodging | $620.57 |
| Food and Beverage | $419.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,863.71 | 2023 | Da Vinci Surgical System, Ion |
| Astrazeneca Pharmaceuticals Lp | $478.96 | 2020-2023 | Fasenra |
| Glaxosmithkline, LLC. | $182.35 | 2021-2024 | Nucala |
| Genzyme Corporation | $98.49 | 2022 | |
| Boston Scientific Corporation | $28.84 | 2023 | Expect |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Potts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.